David Plas - Publications

Affiliations: 
Cell & Molecular Biology University of Cincinnati, Cincinnati, OH 
Area:
Cell Biology

43 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Vallabhapurapu SD, Noothi SK, Pullum DA, Lawrie CH, Pallapati R, Potluri V, Kuntzen C, Khan S, Plas DR, Orlowski RZ, Chesi M, Kuehl WM, Bergsagel PL, Karin M, Vallabhapurapu S. Transcriptional repression by the HDAC4-RelB-p52 complex regulates multiple myeloma survival and growth. Nature Communications. 6: 8428. PMID 26455434 DOI: 10.1038/ncomms9428  1
2015 Shin S, Buel GR, Wolgamott L, Plas DR, Asara JM, Blenis J, Yoon SO. ERK2 Mediates Metabolic Stress Response to Regulate Cell Fate. Molecular Cell. 59: 382-98. PMID 26190261 DOI: 10.1016/J.Molcel.2015.06.020  1
2014 Hall DP, Cost NG, Hegde S, Kellner E, Mikhaylova O, Stratton Y, Ehmer B, Abplanalp WA, Pandey R, Biesiada J, Harteneck C, Plas DR, Meller J, Czyzyk-Krzeska MF. TRPM3 and miR-204 establish a regulatory circuit that controls oncogenic autophagy in clear cell renal cell carcinoma. Cancer Cell. 26: 738-53. PMID 25517751 DOI: 10.1016/J.Ccell.2014.09.015  1
2014 Unruh D, Turner K, Srinivasan R, Kocatürk B, Qi X, Chu Z, Aronow BJ, Plas DR, Gallo CA, Kalthoff H, Kirchhofer D, Ruf W, Ahmad SA, Lucas FV, Versteeg HH, et al. Alternatively spliced tissue factor contributes to tumor spread and activation of coagulation in pancreatic ductal adenocarcinoma. International Journal of Cancer. Journal International Du Cancer. 134: 9-20. PMID 23754313 DOI: 10.1002/ijc.28327  1
2013 Ma L, Tao Y, Duran A, Llado V, Galvez A, Barger JF, Castilla EA, Chen J, Yajima T, Porollo A, Medvedovic M, Brill LM, Plas DR, Riedl SJ, Leitges M, et al. Control of nutrient stress-induced metabolic reprogramming by PKCζ in tumorigenesis. Cell. 152: 599-611. PMID 23374352 DOI: 10.1016/J.Cell.2012.12.028  1
2013 Barger JF, Gallo CA, Tandon P, Liu H, Sullivan A, Grimes HL, Plas DR. S6K1 determines the metabolic requirements for BCR-ABL survival. Oncogene. 32: 453-61. PMID 22391570 DOI: 10.1038/Onc.2012.70  1
2013 Raynor J, Sholl A, Plas DR, Bouillet P, Chougnet CA, Hildeman DA. IL-15 fostersage-driven regulatory T cell accrual in the face of declining IL-2 levels Frontiers in Immunology. 4. DOI: 10.3389/fimmu.2013.00161  1
2012 Czyzyk-Krzeska MF, Meller J, Plas DR. Not all autophagy is equal. Autophagy. 8: 1155-6. PMID 22647376 DOI: 10.4161/Auto.20650  1
2012 Mikhaylova O, Stratton Y, Hall D, Kellner E, Ehmer B, Drew AF, Gallo CA, Plas DR, Biesiada J, Meller J, Czyzyk-Krzeska MF. VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma. Cancer Cell. 21: 532-46. PMID 22516261 DOI: 10.1016/J.Ccr.2012.02.019  1
2012 Aksoylar HI, Lampe K, Barnes MJ, Plas DR, Hoebe K. Loss of immunological tolerance in Gimap5-deficient mice is associated with loss of Foxo in CD4+ T cells. Journal of Immunology (Baltimore, Md. : 1950). 188: 146-54. PMID 22106000 DOI: 10.4049/jimmunol.1101206  1
2011 Sommermann TG, O'Neill K, Plas DR, Cahir-McFarland E. IKKβ and NF-κB transcription govern lymphoma cell survival through AKT-induced plasma membrane trafficking of GLUT1. Cancer Research. 71: 7291-300. PMID 21987722 DOI: 10.1158/0008-5472.CAN-11-1715  1
2011 Zhang Y, Johansson E, Miller ML, Jänicke RU, Ferguson DJ, Plas D, Meller J, Anderson MW. Identification of a conserved anti-apoptotic protein that modulates the mitochondrial apoptosis pathway. Plos One. 6: e25284. PMID 21980415 DOI: 10.1371/Journal.Pone.0025284  1
2011 Giridhar PV, Funk HM, Gallo CA, Porollo A, Mercer CA, Plas DR, Drew AF. Interleukin-6 receptor enhances early colonization of the murine omentum by upregulation of a mannose family receptor, LY75, in ovarian tumor cells. Clinical & Experimental Metastasis. 28: 887-97. PMID 21887537 DOI: 10.1007/s10585-011-9420-x  1
2011 Coloff JL, Macintyre AN, Nichols AG, Liu T, Gallo CA, Plas DR, Rathmell JC. Akt-dependent glucose metabolism promotes Mcl-1 synthesis to maintain cell survival and resistance to Bcl-2 inhibition. Cancer Research. 71: 5204-13. PMID 21670080 DOI: 10.1158/0008-5472.Can-10-4531  1
2011 Tandon P, Gallo CA, Khatri S, Barger JF, Yepiskoposyan H, Plas DR. Requirement for ribosomal protein S6 kinase 1 to mediate glycolysis and apoptosis resistance induced by Pten deficiency. Proceedings of the National Academy of Sciences of the United States of America. 108: 2361-5. PMID 21262837 DOI: 10.1073/Pnas.1013629108  1
2011 Chougnet CA, Tripathi P, Lages CS, Raynor J, Sholl A, Fink P, Plas DR, Hildeman DA. A major role for Bim in regulatory T cell homeostasis Journal of Immunology. 186: 156-163. PMID 21098226 DOI: 10.4049/Jimmunol.1001505  1
2010 Barger JF, Gallo CA, Torni KA, Merk L, Seibel WL, Nelson S, Plas DR. Identification of Akt-selective cytotoxic compounds that enhance cytotoxic responses to rapamycin. Cancer Biology & Therapy. 10: 1256-61. PMID 20935504 DOI: 10.4161/Cbt.10.12.13442  1
2010 Barger JF, Plas DR. Balancing biosynthesis and bioenergetics: metabolic programs in oncogenesis. Endocrine-Related Cancer. 17: R287-304. PMID 20699334 DOI: 10.1677/Erc-10-0106  1
2010 Khatri S, Yepiskoposyan H, Gallo CA, Tandon P, Plas DR. FOXO3a regulates glycolysis via transcriptional control of tumor suppressor TSC1. The Journal of Biological Chemistry. 285: 15960-5. PMID 20371605 DOI: 10.1074/jbc.M110.121871  1
2009 Khatri S, Plas DR. Targeting bioenergetics to enhance cancer chemotherapy: mitochondria SLP into apoptosis. Cancer Biology & Therapy. 8: 1659-61. PMID 19633429 DOI: 10.4161/Cbt.8.17.9456  1
2009 Plas DR, Thomas G. Tubers and tumors: rapamycin therapy for benign and malignant tumors. Current Opinion in Cell Biology. 21: 230-6. PMID 19237273 DOI: 10.1016/j.ceb.2008.12.013  1
2005 Plas DR, Thompson CB. Akt-dependent transformation: there is more to growth than just surviving. Oncogene. 24: 7435-42. PMID 16288290 DOI: 10.1038/Sj.Onc.1209097  1
2005 Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y, Birnbaum MJ, Thompson CB. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Molecular Cell. 18: 283-93. PMID 15866171 DOI: 10.1016/J.Molcel.2005.03.027  1
2005 Plas DR, Kubek S, Buzzai M, Birnbaum MJ, Mu J, Xu Y. An AMPK-p53 connection mediates a checkpoint to inhibit cell proliferation in response to low glucose Cancer Biology and Therapy. 4.  1
2004 Bauer DE, Harris MH, Plas DR, Lum JJ, Hammerman PS, Rathmell JC, Riley JL, Thompson CB. Cytokine stimulation of aerobic glycolysis in hematopoietic cells exceeds proliferative demand. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 18: 1303-5. PMID 15180958 DOI: 10.1096/Fj.03-1001Fje  1
2004 Elstrom RL, Bauer DE, Buzzai M, Karnauskas R, Harris MH, Plas DR, Zhuang H, Cinalli RM, Alavi A, Rudin CM, Thompson CB. Akt stimulates aerobic glycolysis in cancer cells. Cancer Research. 64: 3892-9. PMID 15172999 DOI: 10.1158/0008-5472.Can-03-2904  1
2004 Arsham AM, Plas DR, Thompson CB, Simon MC. Akt and hypoxia-inducible factor-1 independently enhance tumor growth and angiogenesis. Cancer Research. 64: 3500-7. PMID 15150104 DOI: 10.1158/0008-5472.Can-03-2239  1
2003 Rathmell JC, Fox CJ, Plas DR, Hammerman PS, Cinalli RM, Thompson CB. Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival. Molecular and Cellular Biology. 23: 7315-28. PMID 14517300 DOI: 10.1128/Mcb.23.20.7315-7328.2003  1
2003 Karnauskas R, Niu Q, Talapatra S, Plas DR, Greene ME, Crispino JD, Rudin CM. Bcl-x(L) and Akt cooperate to promote leukemogenesis in vivo. Oncogene. 22: 688-98. PMID 12569361 DOI: 10.1038/Sj.Onc.1206159  1
2003 Plas DR, Thompson CB. Akt activation promotes degradation of tuberin and FOXO3a via the proteasome. The Journal of Biological Chemistry. 278: 12361-6. PMID 12517744 DOI: 10.1074/Jbc.M213069200  1
2002 Frauwirth KA, Riley JL, Harris MH, Parry RV, Rathmell JC, Plas DR, Elstrom RL, June CH, Thompson CB. The CD28 signaling pathway regulates glucose metabolism. Immunity. 16: 769-77. PMID 12121659 DOI: 10.1016/S1074-7613(02)00323-0  1
2002 Plas DR, Rathmell JC, Thompson CB. Homeostatic control of lymphocyte survival: potential origins and implications. Nature Immunology. 3: 515-21. PMID 12032565 DOI: 10.1038/Ni0602-515  1
2002 Arsham AM, Plas DR, Thompson CB, Simon MC. Phosphatidylinositol 3-kinase/Akt signaling is neither required for hypoxic stabilization of HIF-1 alpha nor sufficient for HIF-1-dependent target gene transcription. The Journal of Biological Chemistry. 277: 15162-70. PMID 11859074 DOI: 10.1074/Jbc.M111162200  1
2002 Plas DR, Thompson CB. Cell metabolism in the regulation of programmed cell death. Trends in Endocrinology and Metabolism: Tem. 13: 75-8. PMID 11854022 DOI: 10.1016/S1043-2760(01)00528-8  1
2001 Vander Heiden MG, Plas DR, Rathmell JC, Fox CJ, Harris MH, Thompson CB. Growth factors can influence cell growth and survival through effects on glucose metabolism Molecular and Cellular Biology. 21: 5899-5912. PMID 11486029 DOI: 10.1128/Mcb.21.17.5899-5912.2001  1
2001 Plas DR, Talapatra S, Edinger AL, Rathmell JC, Thompson CB. Akt and Bcl-xL promote growth factor-independent survival through distinct effects on mitochondrial physiology. The Journal of Biological Chemistry. 276: 12041-8. PMID 11278698 DOI: 10.1074/Jbc.M010551200  1
1999 Plas DR, Williams CB, Kersh GJ, White LS, White JM, Paust S, Ulyanova T, Allen PM, Thomas ML. Cutting edge: the tyrosine phosphatase SHP-1 regulates thymocyte positive selection. Journal of Immunology (Baltimore, Md. : 1950). 162: 5680-4. PMID 10229799  1
1999 Dustin LB, Plas DR, Wong J, Hu YT, Soto C, Chan AC, Thomas ML. Expression of dominant-negative src-homology domain 2-containing protein tyrosine phosphatase-1 results in increased Syk tyrosine kinase activity and B cell activation. Journal of Immunology (Baltimore, Md. : 1950). 162: 2717-24. PMID 10072516  1
1999 Wang LL, Blasioli J, Plas DR, Thomas ML, Yokoyama WM. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B Journal of Immunology. 162: 1318-1323. PMID 9973385  1
1998 Plas DR, Thomas ML. Negative regulation of antigen receptor signaling in lymphocytes Journal of Molecular Medicine. 76: 589-595. PMID 9694436 DOI: 10.1007/s001090050254  1
1996 Matsumoto M, Lo SF, Carruthers CJL, Min J, Mariathasan S, Huang G, Plas DR, Martin SM, Geha RS, Nahm MH, Chaplin DD. Affinity maturation without germinal centres in lymphotoxin-α- deficient mice Nature. 382: 462-466. PMID 8684487 DOI: 10.1038/382462A0  1
1996 Plas DR, Johnson R, Pingel JT, Matthews RJ, Dalton M, Roy G, Chan AC, Thomas ML. Direct regulation of ZAP-70 by SHP-1 in T cell antigen receptor signaling Science. 272: 1173-1176. PMID 8638162  1
1995 Reinhold MI, Lindberg FP, Plas D, Reynolds S, Peters MG, Brown EJ. In vivo expression of alternatively spliced forms of integrin-associated protein (CD47) Journal of Cell Science. 108: 3419-3425. PMID 8586654  1
Show low-probability matches.